| Recommended Mapping (based on statistical analysis) |
| Source ICD-9 | Mapping Type | Target ICD-10 |
| 99529 (Diagnosis) - Adv eff med/biol NEC/NOS (Unspecified adverse effect of other drug, medicinal and biological substance) with E9412 (Diagnosis) - Adv eff sympathomimetics (Sympathomimetics [adrenergics] causing adverse effects in therapeutic use) | Cluster To Single | T444X5A (Diagnosis) - Adverse effect of predom alpha-adrenocpt agonists, init (Adverse effect of predominantly alpha-adrenoreceptor agonists, initial encounter) |
| CMS/CDC General Equivalence Mappings |
| 99529 (Diagnosis) - Adv eff med/biol NEC/NOS (Unspecified adverse effect of other drug, medicinal and biological substance) with E9412 (Diagnosis) - Adv eff sympathomimetics (Sympathomimetics [adrenergics] causing adverse effects in therapeutic use) | Cluster To Single | Alternative #1: T444X5A (Diagnosis) - Adverse effect of predom alpha-adrenocpt agonists, init (Adverse effect of predominantly alpha-adrenoreceptor agonists, initial encounter) |
Cluster To Single | Alternative #2: T445X5A (Diagnosis) - Adverse effect of predom beta-adrenocpt agonists, init (Adverse effect of predominantly beta-adrenoreceptor agonists, initial encounter) | | Recommended Mapping (based on statistical analysis) |
| Source ICD-9 | Mapping Type | Target ICD-10 |
| 9095 (Diagnosis) - Lte efct advrs efct drug (Late effect of adverse effect of drug, medicinal or biological substance) with E9412 (Diagnosis) - Adv eff sympathomimetics (Sympathomimetics [adrenergics] causing adverse effects in therapeutic use) | Cluster To Single | T444X5S (Diagnosis) - Adverse effect of predom alpha-adrenocpt agonists, sequela (Adverse effect of predominantly alpha-adrenoreceptor agonists, sequela) |
| CMS/CDC General Equivalence Mappings |
| 9095 (Diagnosis) - Lte efct advrs efct drug (Late effect of adverse effect of drug, medicinal or biological substance) with E9412 (Diagnosis) - Adv eff sympathomimetics (Sympathomimetics [adrenergics] causing adverse effects in therapeutic use) | Cluster To Single | Alternative #1: T444X5S (Diagnosis) - Adverse effect of predom alpha-adrenocpt agonists, sequela (Adverse effect of predominantly alpha-adrenoreceptor agonists, sequela) |
Cluster To Single | Alternative #2: T445X5S (Diagnosis) - Adverse effect of predom beta-adrenocpt agonists, sequela (Adverse effect of predominantly beta-adrenoreceptor agonists, sequela) |